Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Breast Cancer

  Free Subscription


Articles published in Clin Breast Cancer

Retrieve available abstracts of 169 articles:
HTML format
Text format



Single Articles


    November 2017
  1. GRANDI G, Toss A, Cagnacci A, Marcheselli L, et al
    Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family History.
    Clin Breast Cancer. 2017 Nov 14. pii: S1526-8209(17)30488.
    PubMed     Text format     Abstract available


    October 2017
  2. JANDIAL R, Hoshide R, Waters JD, Somlo G, et al
    Operative and Therapeutic Advancements in Breast Cancer Metastases to the Brain.
    Clin Breast Cancer. 2017 Oct 7. pii: S1526-8209(17)30417.
    PubMed     Text format     Abstract available


  3. HIEKEN TJ, Murphy BL, Boughey JC, Degnim AC, et al
    Influence of Biologic Subtype of Inflammatory Breast Cancer on Response to Neoadjuvant Therapy and Cancer Outcomes.
    Clin Breast Cancer. 2017 Oct 7. pii: S1526-8209(17)30370.
    PubMed     Text format     Abstract available


  4. HAYASHI N, Takahashi Y, Matsuda N, Tsunoda H, et al
    The Prognostic Effect of Changes in Tumor Stage and Nodal Status After Neoadjuvant Chemotherapy in Each Primary Breast Cancer Subtype.
    Clin Breast Cancer. 2017 Oct 3. pii: S1526-8209(17)30319.
    PubMed     Text format     Abstract available


    September 2017
  5. HOUSSAMI N
    Evidence on Synthesized Two-dimensional Mammography Versus Digital Mammography When Using Tomosynthesis (Three-dimensional Mammography) for Population Breast Cancer Screening.
    Clin Breast Cancer. 2017 Sep 28. pii: S1526-8209(17)30558.
    PubMed     Text format     Abstract available


  6. HEGDE JV, Wang X, Attai DJ, DiNome ML, et al
    Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer.
    Clin Breast Cancer. 2017 Sep 27. pii: S1526-8209(17)30512.
    PubMed     Text format     Abstract available


  7. ITO T, Oura S, Nagamine S, Takahashi M, et al
    Radiofrequency Ablation of Breast Cancer: A Retrospective Study.
    Clin Breast Cancer. 2017 Sep 25. pii: S1526-8209(17)30241.
    PubMed     Text format     Abstract available


  8. LEAL AD, Van Houten H, Sangaralingham L, Freedman RA, et al
    Breast Cancer Survivorship Care Variations Between Adjuvant Chemotherapy Regimens.
    Clin Breast Cancer. 2017 Sep 22. pii: S1526-8209(17)30422.
    PubMed     Text format     Abstract available


  9. AKIMOTO E, Kadoya T, Kajitani K, Emi A, et al
    Role of 18F-PET/CT in Predicting Prognosis of Patients With Breast Cancer After Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(17)30037.
    PubMed     Text format     Abstract available


  10. WU J, Wang S, Liu F, Li S, et al
    Single Nucleotide Polymorphisms in the Acylphosphatase 2 Gene and The SNP-SNP Interactions on the Risk of Breast Cancer in Chinese Han Women.
    Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(17)30157.
    PubMed     Text format     Abstract available


  11. DIANATINASAB M, Mohammadianpanah M, Daneshi N, Zare-Bandamiri M, et al
    Socioeconomic Factors, Health Behavior, and Late-Stage Diagnosis of Breast Cancer: Considering the Impact of Delay in Diagnosis.
    Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(17)30358.
    PubMed     Text format     Abstract available


  12. MANN JM, Wu X, Christos P, Nagar H, et al
    The State of Surgical Axillary Management and Adjuvant Radiotherapy for Early-stage Invasive Breast Cancer in the Modern Era.
    Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(17)30461.
    PubMed     Text format     Abstract available


  13. SAFRA T, Kaufman B, Kadouri L, Efrat Ben-Baruch N, et al
    Everolimus Plus Letrozole for Treatment of Patients With HR+, HER2- Advanced Breast Cancer Progressing on Endocrine Therapy: An Open-label, Phase II Trial.
    Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(17)30180.
    PubMed     Text format     Abstract available


  14. SPINELLI VARELLA MA, Teixeira da Cruz J, Rauber A, Varella IS, et al
    Role of BI-RADS Ultrasound Subcategories 4A to 4C in Predicting Breast Cancer.
    Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(16)30505.
    PubMed     Text format     Abstract available


  15. OBERGUGGENBERGER A, Meraner V, Sztankay M, Hilbert A, et al
    Health Behavior and Quality of Life Outcome in Breast Cancer Survivors: Prevalence Rates and Predictors.
    Clin Breast Cancer. 2017 Sep 18. pii: S1526-8209(17)30454.
    PubMed     Text format     Abstract available


  16. FERNANDEZ-GONZALEZ S, Falo C, Pla MJ, Pernas S, et al
    The Shift From Sentinel Lymph Node Biopsy Performed Either Before or After Neoadjuvant Systemic Therapy in the Clinical Negative Nodes of Breast Cancer Patients. Results, and the Advantages and Disadvantages of Both Procedures.
    Clin Breast Cancer. 2017 Sep 4. pii: S1526-8209(17)30565.
    PubMed     Text format     Abstract available


  17. ANAMPA J, Chen A, Wright J, Patel M, et al
    Phase I Trial of Veliparib, a Poly ADP Ribose Polymerase Inhibitor, Plus Metronomic Cyclophosphamide in Metastatic HER2-negative Breast Cancer.
    Clin Breast Cancer. 2017 Sep 1. pii: S1526-8209(17)30468.
    PubMed     Text format     Abstract available


  18. ROGOZ B, Houze de l'Aulnoit A, Duhamel A, Houze de l'Aulnoit D, et al
    Thirty-Year Trends of Survival and Time-Varying Effects of Prognostic Factors in Patients With Metastatic Breast Cancer-A Single Institution Experience.
    Clin Breast Cancer. 2017 Sep 1. pii: S1526-8209(16)30427.
    PubMed     Text format     Abstract available


    August 2017
  19. CHAMP CE, Ohri N, Klement RJ, Cantor M, et al
    Assessing Changes in the Activity Levels of Breast Cancer Patients During Radiation Therapy.
    Clin Breast Cancer. 2017 Aug 24. pii: S1526-8209(17)30285.
    PubMed     Text format     Abstract available


  20. CHAO YL, Anders CK
    TYMS Gene Polymorphisms in Breast Cancer Patients Receiving 5-Fluorouracil-Based Chemotherapy.
    Clin Breast Cancer. 2017 Aug 19. pii: S1526-8209(17)30369.
    PubMed     Text format    


  21. WANG Y, Brodsky AS, Xiong J, Lopresti ML, et al
    Stromal Clusterin Expression Predicts Therapeutic Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer.
    Clin Breast Cancer. 2017 Aug 19. pii: S1526-8209(17)30349.
    PubMed     Text format     Abstract available


  22. CID S, Eiro N, Fernandez B, Sanchez R, et al
    Prognostic Influence of Tumor Stroma on Breast Cancer Subtypes.
    Clin Breast Cancer. 2017 Aug 19. pii: S1526-8209(17)30189.
    PubMed     Text format     Abstract available


  23. CHOI WJ, Kim WK, Shin HJ, Cha JH, et al
    Evaluation of the Tumor Response After Neoadjuvant Chemotherapy in Breast Cancer Patients: Correlation Between Dynamic Contrast-enhanced Magnetic Resonance Imaging and Pathologic Tumor Cellularity.
    Clin Breast Cancer. 2017 Aug 18. pii: S1526-8209(17)30058.
    PubMed     Text format     Abstract available


  24. AZIM HA, Abdel-Malek R, Kassem L
    Predicting Brain Metastasis in Breast Cancer Patients: Stage Versus Biology.
    Clin Breast Cancer. 2017 Aug 18. pii: S1526-8209(17)30235.
    PubMed     Text format     Abstract available


  25. KOOL M, Bastiaannet E, Van de Velde CJH, Marang-van de Mheen PJ, et al
    Reliability of Self-reported Treatment Data by Patients With Breast Cancer Compared With Medical Record Data.
    Clin Breast Cancer. 2017 Aug 18. pii: S1526-8209(17)30212.
    PubMed     Text format     Abstract available


  26. DONG H, Huang Y, Song F, Dai H, et al
    Improved Performance of Adjunctive Ultrasonography After Mammography Screening for Breast Cancer Among Chinese Females.
    Clin Breast Cancer. 2017 Aug 15. pii: S1526-8209(17)30321.
    PubMed     Text format     Abstract available


  27. CHEN W, Huang Y, Lewis GD, Szeja SS, et al
    Treatment Outcomes and Prognostic Factors in Male Patients With Stage IV Breast Cancer: A Population-based Study.
    Clin Breast Cancer. 2017 Aug 10. pii: S1526-8209(17)30185.
    PubMed     Text format     Abstract available


  28. MOUNSEY LA, Deal AM, Keith KC, Benbow JM, et al
    Changing Natural History of HER2-Positive Breast Cancer Metastatic to the Brain in the Era of New Targeted Therapies.
    Clin Breast Cancer. 2017 Aug 9. pii: S1526-8209(17)30036.
    PubMed     Text format     Abstract available


  29. ZHOU J, Guo FJ, Hao XP, Chen CJ, et al
    Use of Breast Magnetic Resonance Imaging and Ultrasonography for Identifying Nonpalpable Axillae Metastases in Newly Diagnosed Breast Cancer Patients.
    Clin Breast Cancer. 2017 Aug 9. pii: S1526-8209(17)30348.
    PubMed     Text format     Abstract available


    July 2017
  30. LI L, Pan Z
    Progression-Free Survival and Time to Progression as Real Surrogate End Points for Overall Survival in Advanced Breast Cancer: A Meta-Analysis of 37 Trials.
    Clin Breast Cancer. 2017 Jul 25. pii: S1526-8209(16)30358.
    PubMed     Text format     Abstract available


  31. NAMURA M, Tsunoda H, Yagata H, Hayashi N, et al
    Discrepancies Between Pathological Tumor Responses and Estimations of Complete Response by Magnetic Resonance Imaging After Neoadjuvant Chemotherapy Differ by Breast Cancer Subtype.
    Clin Breast Cancer. 2017 Jul 21. pii: S1526-8209(17)30107.
    PubMed     Text format     Abstract available


  32. ALTUNDAG K
    Do We Consider Locoregional Treatment of Primary Site in Patients With De Novo Stage IV Breast Cancer?: Numerous Data Are Accumulating!
    Clin Breast Cancer. 2017 Jul 20. pii: S1526-8209(17)30443.
    PubMed     Text format    


  33. THAKUR KK, Bordoloi D, Kunnumakkara AB
    Alarming Burden of Triple-negative Breast Cancer in India.
    Clin Breast Cancer. 2017 Jul 20. pii: S1526-8209(17)30160.
    PubMed     Text format     Abstract available


  34. GAITANIDIS A, Alevizakos M, Tsalikidis C, Tsaroucha A, et al
    Refusal of Cancer-Directed Surgery by Breast Cancer Patients: Risk Factors and Survival Outcomes.
    Clin Breast Cancer. 2017 Jul 18. pii: S1526-8209(17)30381.
    PubMed     Text format     Abstract available


  35. OTSUBO R, Hirakawa H, Oikawa M, Baba M, et al
    Validation of a Novel Diagnostic Kit Using the Semidry Dot-Blot Method to Detect Metastatic Lymph Nodes in Breast Cancer: Distinguishing Macrometastases From Nonmacrometastases.
    Clin Breast Cancer. 2017 Jul 15. pii: S1526-8209(17)30274.
    PubMed     Text format     Abstract available


  36. PARK AY, Seo BK, Han H, Cho KR, et al
    Clinical Value of Real-Time Ultrasonography-MRI Fusion Imaging for Second-Look Examination in Preoperative Breast Cancer Patients: Additional Lesion Detection and Treatment Planning.
    Clin Breast Cancer. 2017 Jul 14. pii: S1526-8209(17)30167.
    PubMed     Text format     Abstract available


  37. CINAUSERO M, Gerratana L, De Carlo E, Iacono D, et al
    Determinants of Last-line Treatment in Metastatic Breast Cancer.
    Clin Breast Cancer. 2017 Jul 14. pii: S1526-8209(17)30270.
    PubMed     Text format     Abstract available


  38. ALBESHAN SM, Mackey MG, Hossain SZ, Alfuraih AA, et al
    Breast Cancer Epidemiology in Gulf Cooperation Council Countries: A Regional and International Comparison.
    Clin Breast Cancer. 2017 Jul 13. pii: S1526-8209(17)30108.
    PubMed     Text format     Abstract available


  39. BATISTATOU A, Kotoula V, Bobos M, Kouvatseas G, et al
    Correlation of MYC Gene and Protein Status With Breast Cancer Subtypes and Outcome of Patients Treated With Anthracycline-Based Adjuvant Chemotherapy. Pooled Analysis of 2 Hellenic Cooperative Group Phase III Trials.
    Clin Breast Cancer. 2017 Jul 13. pii: S1526-8209(17)30138.
    PubMed     Text format     Abstract available


  40. DESNYDER SM, Mittendorf EA, Le-Petross C, Krishnamurthy S, et al
    Prospective Feasibility Trial of Sentinel Lymph Node Biopsy in the Setting of Inflammatory Breast Cancer.
    Clin Breast Cancer. 2017 Jul 10. pii: S1526-8209(17)30366.
    PubMed     Text format     Abstract available


  41. GERSTL B, Sullivan E, Ives A, Saunders C, et al
    Pregnancy Outcomes After a Breast Cancer Diagnosis: A Systematic Review and Meta-analysis.
    Clin Breast Cancer. 2017 Jul 10. pii: S1526-8209(16)30537.
    PubMed     Text format     Abstract available


  42. OSBORNE C, Challagalla JD, Eisenbeis CF, Holmes FA, et al
    Ixabepilone and Carboplatin for Hormone Receptor Positive/HER2-neu Negative and Triple Negative Metastatic Breast Cancer.
    Clin Breast Cancer. 2017 Jul 10. pii: S1526-8209(16)30521.
    PubMed     Text format     Abstract available


  43. MONTAGNA E, Pirola S, Maisonneuve P, De Roberto G, et al
    Lobular Metastatic Breast Cancer Patients With Gastrointestinal Involvement: Features and Outcomes.
    Clin Breast Cancer. 2017 Jul 10. pii: S1526-8209(17)30085.
    PubMed     Text format     Abstract available


  44. FRATAMICO RS, Strickland KS, Uppal G, Abu-Khalaf M, et al
    A Case of Carcinocythemia: De Novo Hormone Receptor-positive Metastatic Breast Cancer Presenting With Circulating Tumor Cells Mimicking an Acute Leukemia.
    Clin Breast Cancer. 2017 Jul 4. pii: S1526-8209(17)30092.
    PubMed     Text format    


    June 2017
  45. YOKOYAMA S, Tamaru S, Tamaki S, Nakanishi D, et al
    Genetic Risk Factors Associated With Antiemetic Efficacy of Palonosetron, Aprepitant, and Dexamethasone in Japanese Breast Cancer Patients Treated With Anthracycline-based Chemotherapy.
    Clin Breast Cancer. 2017 Jun 29. pii: S1526-8209(17)30142.
    PubMed     Text format     Abstract available


  46. COLLARINO A, de Koster EJ, Valdes Olmos RA, de Geus-Oei LF, et al
    Is Technetium-99m Sestamibi Imaging Able to Predict Pathologic Nonresponse to Neoadjuvant Chemotherapy in Breast Cancer? A Meta-analysis Evaluating Current Use and Shortcomings.
    Clin Breast Cancer. 2017 Jun 29. pii: S1526-8209(17)30059.
    PubMed     Text format     Abstract available


  47. STEGER GG, Dominguez A, Dobrovolskaya N, Giotta F, et al
    Single-Agent Oral Vinorelbine as First-Line Chemotherapy for Endocrine-Pretreated Breast Cancer With Bone Metastases and No Visceral Involvement: NORBREAST-228 Phase II Study.
    Clin Breast Cancer. 2017 Jun 27. pii: S1526-8209(16)30562.
    PubMed     Text format     Abstract available


  48. IBRAHIM M, Muanza T, Smirnow N, Sateren W, et al
    A Pilot Randomized Controlled Trial on the Effects of a Progressive Exercise Program on the Range of Motion and Upper Extremity Grip Strength in Young Adults With Breast Cancer.
    Clin Breast Cancer. 2017 Jun 24. pii: S1526-8209(17)30032.
    PubMed     Text format     Abstract available


  49. CHEN T, Zhang N, Moran MS, Su P, et al
    Borderline ER-Positive Primary Breast Cancer Gains No Significant Survival Benefit From Endocrine Therapy: A Systematic Review and Meta-Analysis.
    Clin Breast Cancer. 2017 Jun 23. pii: S1526-8209(16)30550.
    PubMed     Text format     Abstract available


  50. PARK S, Lee JE, Yu J, Paik HJ, et al
    Risk Factors Affecting Breast Cancer-related Lymphedema: Serial Body Weight Change During Neoadjuvant Anthracycline Plus Cyclophosphamide Followed by Taxane.
    Clin Breast Cancer. 2017 Jun 21. pii: S1526-8209(16)30518.
    PubMed     Text format     Abstract available


  51. CHOI SH, Kim JW, Choi J, Sohn J, et al
    Locoregional Treatment of the Primary Tumor in Patients With De Novo Stage IV Breast Cancer: A Radiation Oncologist's Perspective.
    Clin Breast Cancer. 2017 Jun 17. pii: S1526-8209(17)30306.
    PubMed     Text format     Abstract available


  52. FU J, Wu L, Fu W, Tan Y, et al
    How Young Is Too Young in Breast Cancer?-Young Breast Cancer Is Not a Unique Biological Subtype.
    Clin Breast Cancer. 2017 Jun 8. pii: S1526-8209(17)30033.
    PubMed     Text format     Abstract available


  53. SHAKER OG, Helmy HS
    Circulating Bone-related Markers and YKL-40 Versus HER2 and TOPO2a in Bone Metastatic and Nonmetastatic Breast Cancer: Diagnostic Implications.
    Clin Breast Cancer. 2017 Jun 7. pii: S1526-8209(17)30150.
    PubMed     Text format     Abstract available


  54. ROBERT NJ, Denduluri N
    Patient Case Lessons: Endocrine Management of Advanced Breast Cancer.
    Clin Breast Cancer. 2017 Jun 7. pii: S1526-8209(16)30502.
    PubMed     Text format     Abstract available


    May 2017
  55. YU E, Huang D, Leonard K, Dipetrillo T, et al
    Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer.
    Clin Breast Cancer. 2017 May 25. pii: S1526-8209(17)30115.
    PubMed     Text format     Abstract available


  56. CHO YT, Su H, Chiang YY, Shiea J, et al
    Fine Needle Aspiration Combined With Matrix-assisted Laser Desorption Ionization Time-of-Flight/Mass Spectrometry to Characterize Lipid Biomarkers for Diagnosing Accuracy of Breast Cancer.
    Clin Breast Cancer. 2017 May 25. pii: S1526-8209(16)30538.
    PubMed     Text format     Abstract available


  57. LOURENCO AP, Benson KL, Henderson MC, Silver M, et al
    A Noninvasive Blood-based Combinatorial Proteomic Biomarker Assay to Detect Breast Cancer in Women Under the Age of 50 Years.
    Clin Breast Cancer. 2017 May 23. pii: S1526-8209(16)30412.
    PubMed     Text format     Abstract available


  58. BASELGA J, Zamagni C, Gomez P, Bermejo B, et al
    RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast Cancer.
    Clin Breast Cancer. 2017 May 22. pii: S1526-8209(17)30005.
    PubMed     Text format     Abstract available


  59. ADRASKELA K, Veisaki E, Koutsilieris M, Philippou A, et al
    Physical Exercise Positively Influences Breast Cancer Evolution.
    Clin Breast Cancer. 2017 May 19. pii: S1526-8209(16)30357.
    PubMed     Text format     Abstract available


  60. BUONO G, Giuliano M, De Angelis C, Lauria R, et al
    Pretreatment Serum Concentration of Vitamin D and Breast Cancer Characteristics: A Prospective Observational Mediterranean Study.
    Clin Breast Cancer. 2017 May 19. pii: S1526-8209(17)30168.
    PubMed     Text format     Abstract available


  61. BIGLIA N, Bounous VE, D'Alonzo M, Ottino L, et al
    Vaginal Atrophy in Breast Cancer Survivors: Attitude and Approaches Among Oncologists.
    Clin Breast Cancer. 2017 May 19. pii: S1526-8209(17)30095.
    PubMed     Text format     Abstract available


  62. RAHBAR A, Touma J, Costa H, Davoudi B, et al
    Low Expression of Estrogen Receptor-alpha and Progesterone Receptor in Human Breast Cancer Tissues Is Associated With High-Grade Human Cytomegalovirus Protein Expression.
    Clin Breast Cancer. 2017 May 11. pii: S1526-8209(16)30411.
    PubMed     Text format     Abstract available


  63. NOGI H, Uchida K, Mimoto R, Kamio M, et al
    Long-Term Follow-Up of Node-Negative Breast Cancer Patients Evaluated via Sentinel Node Biopsy After Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2017 May 8. pii: S1526-8209(17)30221.
    PubMed     Text format     Abstract available


  64. HUSSEIN MM, Gaafar RM, Abdel-Warith AM, Ahmed WA, et al
    Efficacy and Toxicity of Metronomic Chemotherapy in Metastatic Breast Cancer: Egyptian Experience.
    Clin Breast Cancer. 2017 May 8. pii: S1526-8209(17)30007.
    PubMed     Text format     Abstract available


  65. DIANATINASAB M, Fararouei M, Mohammadianpanah M, Zare-Bandamiri M, et al
    Hair Coloring, Stress, and Smoking Increase the Risk of Breast Cancer: A Case-Control Study.
    Clin Breast Cancer. 2017 May 5. pii: S1526-8209(17)30135.
    PubMed     Text format     Abstract available


    April 2017
  66. WERNER TL, Ray A, Lamb JG, VanBrocklin M, et al
    A Phase I Study of Neoadjuvant Chemotherapy With Nab-Paclitaxel, Doxorubicin, and Cyclophosphamide in Patients With Stage II to III Breast Cancer.
    Clin Breast Cancer. 2017 Apr 29. pii: S1526-8209(16)30425.
    PubMed     Text format     Abstract available


  67. LI X, Yang J, Krishnamurti U, Huo L, et al
    Hormone Receptor-Positive Breast Cancer Has a Worse Prognosis in Male Than in Female Patients.
    Clin Breast Cancer. 2017 Apr 28. pii: S1526-8209(16)30531.
    PubMed     Text format     Abstract available


  68. EL ZEIN D, Hughes M, Kumar S, Peng X, et al
    Metaplastic Carcinoma of the Breast Is More Aggressive Than Triple-negative Breast Cancer: A Study From a Single Institution and Review of Literature.
    Clin Breast Cancer. 2017 Apr 26. pii: S1526-8209(16)30556.
    PubMed     Text format     Abstract available


  69. MOHAMMADI A, Mansoori B, Baradaran PC, Khaze V, et al
    Urtica dioica Extract Inhibits Proliferation and Induces Apoptosis and Related Gene Expression of Breast Cancer Cells In Vitro and In Vivo.
    Clin Breast Cancer. 2017 Apr 21. pii: S1526-8209(16)30347.
    PubMed     Text format     Abstract available


  70. AMORNSUPAK K, Jamjuntra P, Warnnissorn M, O-Charoenrat P, et al
    High ASMA+ Fibroblasts and Low Cytoplasmic HMGB1+ Breast Cancer Cells Predict Poor Prognosis.
    Clin Breast Cancer. 2017 Apr 21. pii: S1526-8209(16)30580.
    PubMed     Text format     Abstract available


  71. VAN NIJNATTEN TJA, Simons JM, Smidt ML, van der Pol CC, et al
    A Novel Less-invasive Approach for Axillary Staging After Neoadjuvant Chemotherapy in Patients With Axillary Node-positive Breast Cancer by Combining Radioactive Iodine Seed Localization in the Axilla With the Sentinel Node Procedure (RISAS): A Dutch
    Clin Breast Cancer. 2017 Apr 19. pii: S1526-8209(17)30130.
    PubMed     Text format     Abstract available


  72. HERMEL DJ, Wood ME, Chun J, Rounds T, et al
    Multi-institutional Evaluation of Women at High Risk of Developing Breast Cancer.
    Clin Breast Cancer. 2017 Apr 14. pii: S1526-8209(16)30264.
    PubMed     Text format     Abstract available


  73. BELLIO G, Marion R, Giudici F, Kus S, et al
    Interval Breast Cancer Versus Screen-Detected Cancer: Comparison of Clinicopathologic Characteristics in a Single-Center Analysis.
    Clin Breast Cancer. 2017 Apr 11. pii: S1526-8209(17)30174.
    PubMed     Text format     Abstract available


  74. LAMBERTINI M, Ferreira AR, Di Meglio A, Poggio F, et al
    Patterns of Care and Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Newly Diagnosed Stage IV or Recurrent Disease Undergoing First-line Trastuzumab-based Therapy: A Multicenter Retrospective Cohort Study.
    Clin Breast Cancer. 2017 Apr 11. pii: S1526-8209(17)30046.
    PubMed     Text format     Abstract available


  75. MADUNIC J, Horvat L, Majstorovic I, Jodlowska I, et al
    Sodium Salicylate Inhibits Urokinase Activity in MDA MB-231 Breast Cancer Cells.
    Clin Breast Cancer. 2017 Apr 6. pii: S1526-8209(17)30106.
    PubMed     Text format     Abstract available


    March 2017
  76. ZHANG X, Bleiweiss I, Jaffer S, Nayak A, et al
    The Impact of 2013 Updated ASCO/CAP HER2 Guidelines on the Diagnosis and Management of Invasive Breast Cancer: A Single-Center Study of 1739 Cases.
    Clin Breast Cancer. 2017 Mar 29. pii: S1526-8209(16)30360.
    PubMed     Text format     Abstract available


  77. MENDEZ-HERNANDEZ A, Gallegos-Arreola MP, Moreno-Macias H, Espinosa Fematt J, et al
    LEP rs7799039, LEPR rs1137101, and ADIPOQ rs2241766 and 1501299 Polymorphisms Are Associated With Obesity and Chemotherapy Response in Mexican Women With Breast Cancer.
    Clin Breast Cancer. 2017 Mar 22. pii: S1526-8209(16)30246.
    PubMed     Text format     Abstract available


  78. WADASADAWALA T, Vadgaonkar R, Bajpai J
    Management of Isolated Locoregional Recurrences in Breast Cancer: A Review of Local and Systemic Modalities.
    Clin Breast Cancer. 2017 Mar 21. pii: S1526-8209(16)30416.
    PubMed     Text format     Abstract available


  79. GINTER PS, McIntire PJ, Cui X, Irshaid L, et al
    Folate Receptor Alpha Expression Is Associated With Increased Risk of Recurrence in Triple-negative Breast Cancer.
    Clin Breast Cancer. 2017 Mar 21. pii: S1526-8209(17)30012.
    PubMed     Text format     Abstract available


  80. VIDAL GA, Chen M, Sheth S, Svahn T, et al
    Phase I Trial of Everolimus and Capecitabine in Metastatic HER2- Breast Cancer.
    Clin Breast Cancer. 2017 Mar 16. pii: S1526-8209(16)30410.
    PubMed     Text format     Abstract available


  81. BERNARDO A, Palumbo R, Pedersini R, Rota Caremoli E, et al
    Nab-Paclitaxel in Advanced HER2-negative Breast Cancer Patients: Efficacy and Safety Beyond Clinical Trials.
    Clin Breast Cancer. 2017 Mar 9. pii: S1526-8209(16)30359.
    PubMed     Text format     Abstract available


  82. CHAND AR, Ziauddin MF, Tang SC
    Can Locoregionally Recurrent Breast Cancer Be Cured?
    Clin Breast Cancer. 2017 Mar 2. pii: S1526-8209(17)30113.
    PubMed     Text format     Abstract available


    February 2017
  83. ALTUNDAG K
    Flap Fixation Using Tissue Glue or Sutures After Mastectomy Might Also Reduce Risk of Developing Lymphedema in Breast Cancer.
    Clin Breast Cancer. 2017 Feb 20. pii: S1526-8209(17)30061.
    PubMed     Text format    


  84. ALTUNDAG K
    Molecular Subtypes and Lower Inner Quadrant Tumors in Breast Cancer: Debate Is Still Ongoing.
    Clin Breast Cancer. 2017 Feb 17. pii: S1526-8209(17)30019.
    PubMed     Text format    


  85. REZENDE LM, Marson FA, Lima CS, Bertuzzo CS, et al
    Can MTHFR C677T and A1298C Polymorphisms Alter the Risk and Severity of Sporadic Breast Cancer in Brazilian Women?
    Clin Breast Cancer. 2017 Feb 16. pii: S1526-8209(16)30341.
    PubMed     Text format     Abstract available


  86. WANG CH, Chang CJ, Yeh KY, Chang PH, et al
    The Prognostic Value of HER2-Positive Circulating Tumor Cells in Breast Cancer Patients: A Systematic Review and Meta-Analysis.
    Clin Breast Cancer. 2017 Feb 16. pii: S1526-8209(17)30086.
    PubMed     Text format     Abstract available


    January 2017
  87. LEFEUVRE D, Le Bihan-Benjamin C, Pauporte I, Medioni J, et al
    French Medico-Administrative Data to Identify the Care Pathways of Women With Breast Cancer.
    Clin Breast Cancer. 2017 Jan 27. pii: S1526-8209(16)30321.
    PubMed     Text format     Abstract available


  88. VAN BASTELAAR J, Theunissen LL, Snoeijs MG, Beets GL, et al
    Flap Fixation Using Tissue Glue or Sutures Appears to Reduce Seroma Aspiration After Mastectomy for Breast Cancer.
    Clin Breast Cancer. 2017 Jan 24. pii: S1526-8209(16)30565.
    PubMed     Text format     Abstract available


  89. DE BOER MC, Worner EA, Verlaan D, van Leeuwen PA, et al
    The Mechanisms and Effects of Physical Activity on Breast Cancer.
    Clin Breast Cancer. 2017 Jan 24. pii: S1526-8209(16)30422.
    PubMed     Text format     Abstract available


  90. CHAPMAN JW, Liu S, Leung S, Nielsen TO, et al
    Competing Risks of Mortality by PAM50 Intrinsic Subtype of British Columbia Tamoxifen-Treated Cohort of Postmenopausal Patients With Breast Cancer.
    Clin Breast Cancer. 2017 Jan 20. pii: S1526-8209(16)30362.
    PubMed     Text format     Abstract available


  91. LI G, Xu Z, Zhuang A, Chang S, et al
    Magnetic Resonance Spectroscopy-Detected Change in Marrow Adiposity Is Strongly Correlated to Postmenopausal Breast Cancer Risk.
    Clin Breast Cancer. 2017 Jan 18. pii: S1526-8209(17)30011.
    PubMed     Text format     Abstract available


  92. GHONCHEH M, Ziaee F, Karami M, Poorolajal J, et al
    Validating the IBIS and BOADICEA Models for Predicting Breast Cancer Risk in the Iranian Population.
    Clin Breast Cancer. 2017 Jan 18. pii: S1526-8209(17)30010.
    PubMed     Text format     Abstract available


  93. GU YL, Pan SM, Ren J, Yang ZX, et al
    Role of Magnetic Resonance Imaging in Detection of Pathologic Complete Remission in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: A Meta-analysis.
    Clin Breast Cancer. 2017 Jan 11. pii: S1526-8209(16)30256.
    PubMed     Text format     Abstract available


  94. SCHRAMM A, Schochter F, Friedl TW, de Gregorio N, et al
    Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast Cancer.
    Clin Breast Cancer. 2017 Jan 10. pii: S1526-8209(16)30257.
    PubMed     Text format     Abstract available


  95. HWANG KT, Kim J, Kim EK, Jung SH, et al
    Poor Prognosis of Lower Inner Quadrant in Lymph Node-negative Breast Cancer Patients Who Received No Chemotherapy: A Study Based on Nationwide Korean Breast Cancer Registry Database.
    Clin Breast Cancer. 2017 Jan 10. pii: S1526-8209(16)30269.
    PubMed     Text format     Abstract available


  96. CONVERSANO A, Mazouni C, Thomin A, Gaudin A, et al
    Use of Low-Thrombin Fibrin Sealant Glue After Axillary Lymphadenectomy for Breast Cancer to Reduce Hospital Length and Seroma.
    Clin Breast Cancer. 2017 Jan 10. pii: S1526-8209(16)30449.
    PubMed     Text format     Abstract available


  97. GOLSE N, Adam R
    Liver Metastases From Breast Cancer: What Role for Surgery? Indications and Results.
    Clin Breast Cancer. 2017 Jan 9. pii: S1526-8209(16)30298.
    PubMed     Text format     Abstract available


  98. NYE L, Rademaker A, Gradishar WJ
    Breast Cancer Outcomes After Diagnosis of Hormone-positive Breast Cancer and Subsequent Pregnancy in the Tamoxifen Era.
    Clin Breast Cancer. 2017 Jan 9. pii: S1526-8209(16)30313.
    PubMed     Text format     Abstract available


  99. MURPHY BL, Boughey JC, Hieken TJ
    Nipple-sparing Mastectomy for the Management of Recurrent Breast Cancer.
    Clin Breast Cancer. 2017 Jan 9. pii: S1526-8209(16)30355.
    PubMed     Text format     Abstract available


  100. ALTUNDAG K
    New Data About First-line All-oral Vinorelbine and Capecitabine in HER2-negative Metastatic Breast Cancer Confirms Results of Meta-analysis.
    Clin Breast Cancer. 2017 Jan 9. pii: S1526-8209(16)30426.
    PubMed     Text format    


  101. ALTUNDAG K
    Genomic Profiling of Brain Metastasis and Matched Primary Triple-negative Breast Cancer.
    Clin Breast Cancer. 2017 Jan 9. pii: S1526-8209(16)30409.
    PubMed     Text format    


  102. SHEPPARD VB, Cavalli LR, Dash C, Kanaan YM, et al
    Correlates of Triple Negative Breast Cancer and Chemotherapy Patterns in Black and White Women With Breast Cancer.
    Clin Breast Cancer. 2017 Jan 6. pii: S1526-8209(16)30571.
    PubMed     Text format     Abstract available


  103. DENU RA, Burkard ME
    Synchronous Bilateral Breast Cancer in a Patient With Nager Syndrome.
    Clin Breast Cancer. 2017 Jan 5. pii: S1526-8209(16)30577.
    PubMed     Text format    


    December 2016
  104. JONES EF, Ray KM, Li W, Seo Y, et al
    Dedicated Breast Positron Emission Tomography for the Evaluation of Early Response to Neoadjuvant Chemotherapy in Breast Cancer.
    Clin Breast Cancer. 2016 Dec 29. pii: S1526-8209(16)30576.
    PubMed     Text format    


  105. YAN M, Wang J, Xuan Q, Dong T, et al
    The Relationship Between Tamoxifen-associated Nonalcoholic Fatty Liver Disease and the Prognosis of Patients With Early-stage Breast Cancer.
    Clin Breast Cancer. 2016 Dec 24. pii: S1526-8209(16)30569.
    PubMed     Text format     Abstract available


  106. AL-BAHLANI SM, Al-Bulushi KH, Al-Alawi ZM, Al-Abri NY, et al
    Cisplatin Induces Apoptosis Through the Endoplasmic Reticulum-mediated, Calpain 1 Pathway in Triple-negative Breast Cancer Cells.
    Clin Breast Cancer. 2016 Dec 24. pii: S1526-8209(16)30566.
    PubMed     Text format     Abstract available


  107. PEREIRA CB, Leal MF, Abdelhay ES, Demachki S, et al
    MYC Amplification as a Predictive Factor of Complete Pathologic Response to Docetaxel-based Neoadjuvant Chemotherapy for Breast Cancer.
    Clin Breast Cancer. 2016 Dec 24. pii: S1526-8209(16)30570.
    PubMed     Text format     Abstract available


  108. BENEDICT C, Thom B, Teplinsky E, Carleton J, et al
    Family-building After Breast Cancer: Considering the Effect on Adherence to Adjuvant Endocrine Therapy.
    Clin Breast Cancer. 2016 Dec 24. pii: S1526-8209(16)30567.
    PubMed     Text format     Abstract available


    November 2016
  109. XIAO F, Song X, Chen Q, Dai Y, et al
    Effectiveness of Psychological Interventions on Depression in Patients After Breast Cancer Surgery: A Meta-analysis of Randomized Controlled Trials.
    Clin Breast Cancer. 2016 Nov 23. pii: S1526-8209(16)30494.
    PubMed     Text format     Abstract available


  110. GIATROMANOLAKI A, Sivridis E, Kalamida D, Koukourakis MI, et al
    Transcription Factor EB Expression in Early Breast Cancer Relates to Lysosomal/Autophagosomal Markers and Prognosis.
    Clin Breast Cancer. 2016 Nov 23. pii: S1526-8209(16)30497.
    PubMed     Text format     Abstract available


  111. TSENG CH
    Sitagliptin May Reduce Breast Cancer Risk in Women With Type 2 Diabetes.
    Clin Breast Cancer. 2016 Nov 23. pii: S1526-8209(16)30493.
    PubMed     Text format     Abstract available


  112. SATO K, Akimoto K
    Expression Levels of KMT2C and SLC20A1 Identified by Information-theoretical Analysis Are Powerful Prognostic Biomarkers in Estrogen Receptor-positive Breast Cancer.
    Clin Breast Cancer. 2016 Nov 23. pii: S1526-8209(16)30496.
    PubMed     Text format     Abstract available


  113. VILLARREAL-GARZA C, Mohar A, Bargallo-Rocha JE, Lasa-Gonsebatt F, et al
    Molecular Subtypes and Prognosis in Young Mexican Women With Breast Cancer.
    Clin Breast Cancer. 2016 Nov 23. pii: S1526-8209(16)30498.
    PubMed     Text format     Abstract available


  114. MUZAFFAR M, Kachare S, Vohra N
    Impact of Primary Tumor Surgery in Stage IV Male Breast Cancer.
    Clin Breast Cancer. 2016 Nov 22. pii: S1526-8209(16)30492.
    PubMed     Text format     Abstract available


    October 2016
  115. RYU JM, Park S, Paik HJ, Nam SJ, et al
    Oncologic Safety of Immediate Breast Reconstruction in Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy: Short-Term Outcomes of a Matched Case-Control Study.
    Clin Breast Cancer. 2016 Oct 27. pii: S1526-8209(16)30373.
    PubMed     Text format     Abstract available


  116. KIM SH, Shin HJ, Shin KC, Chae EY, et al
    Diagnostic Performance of Fused Diffusion-Weighted Imaging Using T1-Weighted Imaging for Axillary Nodal Staging in Patients With Early Breast Cancer.
    Clin Breast Cancer. 2016 Oct 19. pii: S1526-8209(16)30374.
    PubMed     Text format     Abstract available


  117. OJINNAKA CO, Luo W, Ory MG, McMaughan D, et al
    Disparities in Surgical Treatment of Early-Stage Breast Cancer Among Female Residents of Texas: The Role of Racial Residential Segregation.
    Clin Breast Cancer. 2016 Oct 19. pii: S1526-8209(16)30370.
    PubMed     Text format     Abstract available


  118. LEINERT E, Singer S, Janni W, Harbeck N, et al
    The Impact of Age on Quality of Life in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Comparative Analysis From the Prospective Multicenter Randomized ADEBAR trial.
    Clin Breast Cancer. 2016 Oct 19. pii: S1526-8209(16)30372.
    PubMed     Text format     Abstract available


  119. MARRAZZO A, Damiano G, Taormina P, Buscemi S, et al
    Does Conservative Surgery for Breast Carcinoma Still Require Axillary Lymph Node Evaluation? A Retrospective Analysis of 1156 Consecutive Women With Early Breast Cancer.
    Clin Breast Cancer. 2016 Oct 18. pii: S1526-8209(16)30365.
    PubMed     Text format     Abstract available


    September 2016
  120. DUCHNOWSKA R, Jarzab M, Zebracka-Gala J, Matkowski R, et al
    Brain Metastasis Prediction by Transcriptomic Profiling in Triple-Negative Breast Cancer.
    Clin Breast Cancer. 2016 Sep 8. pii: S1526-8209(16)30238.
    PubMed     Text format     Abstract available


    August 2016
  121. GAO JJ, Tan M, Pohlmann PR, Swain SM, et al
    HALT-D: A Phase II Evaluation of Crofelemer for the Prevention and Prophylaxis of Diarrhea in Patients With Breast Cancer on Pertuzumab-Based Regimens.
    Clin Breast Cancer. 2016 Aug 27. pii: S1526-8209(16)30235.
    PubMed     Text format     Abstract available


  122. GLUCK S
    Consequences of the Convergence of Multiple Alternate Pathways on the Estrogen Receptor in the Treatment of Metastatic Breast Cancer.
    Clin Breast Cancer. 2016 Aug 25. pii: S1526-8209(16)30234.
    PubMed     Text format     Abstract available


  123. PIVO S, Montes J, Schwartz S, Chun J, et al
    Breast Cancer Risk Assessment and Screening in Transgender Patients.
    Clin Breast Cancer. 2016 Aug 25. pii: S1526-8209(16)30233.
    PubMed     Text format    


  124. JASRA S, Opyrchal M, Norton L, Mehta R, et al
    A Rare Case of S310F Somatic ERBB2 Mutation in a HER2-Nonamplified Breast Cancer.
    Clin Breast Cancer. 2016 Aug 18. pii: S1526-8209(16)30211.
    PubMed     Text format    


  125. CADOO KA, Morris PG, Cowell EP, Patil S, et al
    Adjuvant Chemotherapy and Trastuzumab Is Safe and Effective in Older Women With Small, Node-Negative, HER2-Positive Early-Stage Breast Cancer.
    Clin Breast Cancer. 2016 Aug 1. pii: S1526-8209(16)30206.
    PubMed     Text format     Abstract available


    July 2016
  126. YARDLEY DA, Reeves J, Dees EC, Osborne C, et al
    Ramucirumab With Eribulin Versus Eribulin in Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracycline and Taxane Therapy: A Multicenter, Randomized, Phase II Study.
    Clin Breast Cancer. 2016 Jul 29. pii: S1526-8209(16)30198.
    PubMed     Text format     Abstract available


  127. CHOI WJ, Cha JH, Kim HH, Shin HJ, et al
    The Accuracy of Breast MR Imaging for Measuring the Size of a Breast Cancer: Analysis of the Histopathologic Factors.
    Clin Breast Cancer. 2016 Jul 29. pii: S1526-8209(16)30200.
    PubMed     Text format     Abstract available


  128. DUDANI S, Mazzarello S, Hilton J, Hutton B, et al
    Optimal Management of Leptomeningeal Carcinomatosis in Breast Cancer Patients-A Systematic Review.
    Clin Breast Cancer. 2016 Jul 28. pii: S1526-8209(16)30207.
    PubMed     Text format     Abstract available


  129. XUAN Q, Gao K, Song Y, Zhao S, et al
    Adherence to Needed Adjuvant Therapy Could Decrease Recurrence Rates for Rural Patients With Early Breast Cancer.
    Clin Breast Cancer. 2016 Jul 28. pii: S1526-8209(16)30199.
    PubMed     Text format     Abstract available


  130. ZHU W, Harvey S, Macura KJ, Euhus DM, et al
    Invasive Breast Cancer Preferably and Predominantly Occurs at the Interface Between Fibroglandular and Adipose Tissue.
    Clin Breast Cancer. 2016 Jul 28. pii: S1526-8209(16)30202.
    PubMed     Text format     Abstract available


  131. TECALCO-CRUZ AC, Ramirez-Jarquin JO
    Mechanisms that Increase Stability of Estrogen Receptor Alpha in Breast Cancer.
    Clin Breast Cancer. 2016 Jul 28. pii: S1526-8209(16)30208.
    PubMed     Text format     Abstract available


  132. WILKINSON JB, Shah C, Amin M, Nadeau L, et al
    Outcomes According to Breast Cancer Subtype in Patients Treated With Accelerated Partial Breast Irradiation.
    Clin Breast Cancer. 2016 Jul 28. pii: S1526-8209(16)30203.
    PubMed     Text format     Abstract available


  133. SMITH JW 2ND, Buyse ME, Rastogi P, Geyer CE Jr, et al
    Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Tri
    Clin Breast Cancer. 2016 Jul 28. pii: S1526-8209(16)30201.
    PubMed     Text format     Abstract available


  134. MORIKAWA A, Jordan L, Rozner R, Patil S, et al
    Characteristics and Outcomes of Patients With Breast Cancer With Leptomeningeal Metastasis.
    Clin Breast Cancer. 2016 Jul 25. pii: S1526-8209(16)30177.
    PubMed     Text format     Abstract available


  135. EDENFIELD J, Schammel C, Collins J, Schammel D, et al
    Metaplastic Breast Cancer: Molecular Typing and Identification of Potential Targeted Therapies at a Single Institution.
    Clin Breast Cancer. 2016 Jul 25. pii: S1526-8209(16)30197.
    PubMed     Text format     Abstract available


  136. FOGLIETTA J, Inno A, de Iuliis F, Sini V, et al
    Cardiotoxicity of Aromatase Inhibitors in Breast Cancer Patients.
    Clin Breast Cancer. 2016 Jul 25. pii: S1526-8209(16)30196.
    PubMed     Text format     Abstract available


  137. HARRIS SR
    Differentiating the Causes of Spontaneous Rib Fracture After Breast Cancer.
    Clin Breast Cancer. 2016 Jul 15. pii: S1526-8209(16)30176.
    PubMed     Text format     Abstract available


  138. PARK S, Lee JE, Paik HJ, Ryu JM, et al
    Feasibility and Prognostic Effect of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Cytology-Proven, Node-Positive Breast Cancer.
    Clin Breast Cancer. 2016 Jul 9. pii: S1526-8209(16)30175.
    PubMed     Text format     Abstract available


  139. TANAKA K, Tokunaga E, Inoue Y, Yamashita N, et al
    Impact of Expression of Vimentin and Axl in Breast Cancer.
    Clin Breast Cancer. 2016 Jul 5. pii: S1526-8209(16)30170.
    PubMed     Text format     Abstract available


  140. S CHAPMAN J, Roddy E, Panighetti A, Hwang S, et al
    Comparing Coordinated Versus Sequential Salpingo-Oophorectomy for BRCA1 and BRCA2 Mutation Carriers With Breast Cancer.
    Clin Breast Cancer. 2016 Jul 5. pii: S1526-8209(16)30171.
    PubMed     Text format     Abstract available


    June 2016
  141. LEE J, Jung JH, Kim WW, Hwang SO, et al
    Five-Year Oncologic Outcomes of Volume Displacement Procedures After Partial Mastectomy for Breast Cancer.
    Clin Breast Cancer. 2016 Jun 29. pii: S1526-8209(16)30173.
    PubMed     Text format     Abstract available


  142. NAVARRO-RODRIGUEZ E, Diaz-Jimenez N, Ruiz-Rabelo J, Gomez-Luque I, et al
    Factors Associated With Disease Recurrence in Breast Cancer Patients With Negative Sentinel Lymph Node Biopsy.
    Clin Breast Cancer. 2016 Jun 27. pii: S1526-8209(16)30168.
    PubMed     Text format     Abstract available


  143. VARILLA V, Taxel P, Tannenbaum S
    Metastatic Inflammatory Breast Cancer Associated With Multicentric Reticulohistiocytosis Successfully Treated With Zoledronic Acid.
    Clin Breast Cancer. 2016 Jun 25. pii: S1526-8209(16)30166.
    PubMed     Text format    


  144. DE IULIIS F, Salerno G, Corvino R, D'Aniello D, et al
    Anthracycline-Free Neoadjuvant Chemotherapy Ensures Higher Rates of Pathologic Complete Response in Breast Cancer.
    Clin Breast Cancer. 2016 Jun 25. pii: S1526-8209(16)30165.
    PubMed     Text format     Abstract available


  145. ONO M, Tsuda H, Yoshida M, Shimizu C, et al
    Prognostic Significance of Progesterone Receptor Expression in Estrogen-Receptor Positive, HER2-Negative, Node-Negative Invasive Breast Cancer With a Low Ki-67 Labeling Index.
    Clin Breast Cancer. 2016 Jun 25. pii: S1526-8209(16)30167.
    PubMed     Text format     Abstract available


  146. CINIERI S, Chan A, Altundag K, Vandebroek A, et al
    Final Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast Cancer.
    Clin Breast Cancer. 2016 Jun 25. pii: S1526-8209(16)30169.
    PubMed     Text format     Abstract available


  147. DAUGHERTY EC, Daugherty MR, Bogart JA, Shapiro A, et al
    Adjuvant Radiation Improves Survival in Older Women Following Breast-Conserving Surgery for Estrogen Receptor-Negative Breast Cancer.
    Clin Breast Cancer. 2016 Jun 23. pii: S1526-8209(16)30172.
    PubMed     Text format     Abstract available


  148. RAMAN R, Mott SL, Schroeder MC, Phadke S, et al
    Effect of Body Mass Index- and Actual Weight-Based Neoadjuvant Chemotherapy Doses on Pathologic Complete Response in Operable Breast Cancer.
    Clin Breast Cancer. 2016 Jun 23. pii: S1526-8209(16)30163.
    PubMed     Text format     Abstract available


  149. BUFI E, Belli P, Di Matteo M, Giuliani M, et al
    Hypervascularity Predicts Complete Pathologic Response to Chemotherapy and Late Outcomes in Breast Cancer.
    Clin Breast Cancer. 2016 Jun 23. pii: S1526-8209(16)30162.
    PubMed     Text format     Abstract available


  150. TAKAHASHI H, Kagara N, Tanei T, Naoi Y, et al
    Correlation of Methylated Circulating Tumor DNA With Response to Neoadjuvant Chemotherapy in Breast Cancer Patients.
    Clin Breast Cancer. 2016 Jun 16. pii: S1526-8209(16)30148.
    PubMed     Text format     Abstract available


  151. TZANNINIS IG, Kotteas EA, Ntanasis-Stathopoulos I, Kontogianni P, et al
    Management and Outcomes in Metaplastic Breast Cancer.
    Clin Breast Cancer. 2016 Jun 15. pii: S1526-8209(16)30144.
    PubMed     Text format     Abstract available


  152. GIULIANI M, Patrolecco F, Rella R, Di Giovanni SE, et al
    Can Breast Cancer Biopsy Influence Sentinel Lymph Node Status?
    Clin Breast Cancer. 2016 Jun 14. pii: S1526-8209(16)30147.
    PubMed     Text format     Abstract available


  153. JEHN CF, Hemmati P, Lehenbauer-Dehm S, Kummel S, et al
    Biweekly Pegylated Liposomal Doxorubicin (Caelyx) in Heavily Pretreated Metastatic Breast Cancer: A Phase 2 Study.
    Clin Breast Cancer. 2016 Jun 14. pii: S1526-8209(16)30143.
    PubMed     Text format     Abstract available


  154. ABRAMOVITZ M, Williams C, Loibl S, Leyland-Jones B, et al
    Dual Blockade of HER-2 Provides a Greater Magnitude of Benefit in Patients With Hormone-Negative Versus Hormone-Positive Breast Cancer.
    Clin Breast Cancer. 2016 Jun 14. pii: S1526-8209(16)30146.
    PubMed     Text format     Abstract available


  155. AYTAC HO, Nursal TZ, Colakoglu T, Bolat FA, et al
    Seroma Cytology in Breast Cancer: An Underappreciated Issue.
    Clin Breast Cancer. 2016 Jun 8. pii: S1526-8209(16)30142.
    PubMed     Text format     Abstract available


  156. CEBERIO N, Cuadra M, Mendizabal JL, Gorostiaga J, et al
    Should We Perform the Intraoperative Sentinel Lymph Node Biopsy in Breast Cancer?
    Clin Breast Cancer. 2016 Jun 8. pii: S1526-8209(16)30141.
    PubMed     Text format     Abstract available


  157. TAKEI J, Tsunoda H, Yagata H, Suzuki K, et al
    Sustained Interruption of Anterior Interfaces Between Adipose Tissues and Mammary Glands in Ultrasonography After Complete Pathological Remission After Neoadjuvant Chemotherapy for Primary Breast Cancer.
    Clin Breast Cancer. 2016;16:196-201.
    PubMed     Text format     Abstract available


    May 2016
  158. NEUHAUS V, Abdullayev N, Hellmich M, Kramer S, et al
    Association of Quality and Quantity of Bone Metastases and Computed Tomography Volumetric Bone Mineral Density With Prevalence of Vertebral Fractures in Breast Cancer Patients.
    Clin Breast Cancer. 2016 May 31. pii: S1526-8209(16)30106.
    PubMed     Text format     Abstract available


  159. SHIINO S, Kinoshita T, Yoshida M, Jimbo K, et al
    Prognostic Impact of Discordance in Hormone Receptor Status Between Primary and Recurrent Sites in Patients With Recurrent Breast Cancer.
    Clin Breast Cancer. 2016 May 14. pii: S1526-8209(16)30110.
    PubMed     Text format     Abstract available


  160. AZGHADI S, Daly M, Mayadev J
    Practice Patterns of Radiation Field Design for Sentinel Lymph Node-Positive Early-Stage Breast Cancer.
    Clin Breast Cancer. 2016 May 14. pii: S1526-8209(16)30105.
    PubMed     Text format     Abstract available


  161. NAKAUCHI C, Kagara N, Shimazu K, Shimomura A, et al
    Detection of TP53/PIK3CA Mutations in Cell-Free Plasma DNA From Metastatic Breast Cancer Patients Using Next Generation Sequencing.
    Clin Breast Cancer. 2016 May 14. pii: S1526-8209(16)30100.
    PubMed     Text format     Abstract available


  162. YARDLEY DA, Ward PJ, Daniel BR, Eakle JF, et al
    Panitumumab, Gemcitabine, and Carboplatin as Treatment for Women With Metastatic Triple-Negative Breast Cancer: A Sarah Cannon Research Institute Phase II Trial.
    Clin Breast Cancer. 2016 May 14. pii: S1526-8209(16)30102.
    PubMed     Text format     Abstract available


  163. GANZ PA, Hahn EE, Petersen L, Melisko ME, et al
    Quality of Posttreatment Care Among Breast Cancer Survivors in the University of California Athena Breast Health Network (Athena).
    Clin Breast Cancer. 2016 May 14. pii: S1526-8209(16)30099.
    PubMed     Text format     Abstract available


  164. TANG Y, Wang Y, Kiani MF, Wang B, et al
    Classification, Treatment Strategy, and Associated Drug Resistance in Breast Cancer.
    Clin Breast Cancer. 2016 May 13. pii: S1526-8209(16)30108.
    PubMed     Text format     Abstract available


  165. CHANG JS, Chen J, Weinberg VK, Fowble B, et al
    Evaluation of Heart Dose for Left-Sided Breast Cancer Patients Over an 11-Year Period Spanning the Transition From 2-Dimensional to 3-Dimensional Planning.
    Clin Breast Cancer. 2016 May 13. pii: S1526-8209(16)30109.
    PubMed     Text format     Abstract available


  166. ALGAN O, Zhao YD, Herman T
    Radiotherapy in Patients 70 Years and Older With Triple-Negative Breast Cancer.
    Clin Breast Cancer. 2016 May 13. pii: S1526-8209(16)30107.
    PubMed     Text format     Abstract available


  167. PETRELLI F, Di Cosimo S, Lonati V, Barni S, et al
    Vinorelbine With Capecitabine, an Evergreen Doublet for Advanced Breast Cancer: A Systematic Literature Review and Pooled-Analysis of Phase II-III Studies.
    Clin Breast Cancer. 2016 May 13. pii: S1526-8209(16)30098.
    PubMed     Text format     Abstract available


    April 2016
  168. HAMELINCK VC, Bastiaannet E, Pieterse AH, de Glas NA, et al
    A Prospective Comparison of Younger and Older Patients' Preferences for Adjuvant Chemotherapy and Hormonal Therapy in Early Breast Cancer.
    Clin Breast Cancer. 2016 Apr 21. pii: S1526-8209(16)30083.
    PubMed     Text format     Abstract available


    March 2016
  169. OHNO S
    Tolerability of Therapies Recommended for the Treatment of Hormone Receptor-Positive Locally Advanced or Metastatic Breast Cancer.
    Clin Breast Cancer. 2016 Mar 12. pii: S1526-8209(16)30049.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: